PODCAST: A Biotech Buyout, and an Influencer Uprising

By Doug Young & Rene Vanguestaine

AstraZeneca has offered to buy money-losing Gracell Biotech for up to $1.2 billion, in a first-of-its kind M&A for a Chinese drug startup. Will China approve the deal? And e-commerce company East Buy’s CEO gets sacked under pressure from its top online salesman. How much power do such influencers wield at Chinese internet companies?

About China Inc

China Inc by Bamboo Works discusses the latest developments on Chinese companies listed in Hong Kong and the United States to drive informed decision-making for investors and others interested in this dynamic group of companies.

Subscribe to China Inc on your favorite app:

Apple Podcasts

Spotify